70 likes | 155 Views
The leading pharmaceutical players continue to face the combined threats of a difficult operating environment and patent losses while struggling to deliver on pipeline potential. Externalization strategies are a key means to boost future revenues and, indeed more imminently, to satisfy shareholder demands. Browse full report @ http://goo.gl/INmidr
E N D
Category : Healthcare Market Research Reports Biopharma M&A and Deal Making - Understanding the Latest Trends to Optimize Future Strategy www.aarkstore.com
Summary The leading pharmaceutical players continue to face the combined threats of a difficult operating environment and patent losses while struggling to deliver on pipeline potential. Externalization strategies are a key means to boost future revenues and, indeed more imminently, to satisfy shareholder demands. However, the increasing size of the leading biopharmaceutical companies is necessitating their involvement in growing the numbers and size of deals year by year. This in itself, along with the rising financial firepower of the mid-tier players, has increased the level of competition for the most attractive targets. Increased competition in the marketplace for M&A and licensing deals can artificially inflate the cost of these deals, distorting the balance of value, risk and return. As a result companies must employ more rigorous selection processes and expand search criteria to consider more diverse options if they are to maximize their returns on investment. www.aarkstore.com
Scope - Trends in recent deal activity- Successful deal making- Future deal activity Browse Complete Report - http://www.aarkstore.com/healthcare/109260/biopharma-ma-and-deal-making-understanding-the-latest-trends-to-optimize-future-strategy www.aarkstore.com
Key Reasons to Purchase - Understand and evaluate the strategies being used by companies of all sizes to support future revenue growth- Benefit from CBR’s case study analysis of the different types of deals being done in the current & future biopharma industry- Access data and trends analysis of the types of deals taking place and which therapeutic areas are showing the most activity- Gain insights around the steps that need to be taken in order to best secure a successful deal- Learn who the key companies are to watch for in the coming year, the motivations behind the deals they are doing, and identify which ones relate to your business strategies www.aarkstore.com
Table of Content Executive SummaryChapter 1: Introduction What is driving the increased use of externalization in biopharma industry strategiesExternalization strategies: the options Benefits of different deal types from M&A to arms length licensingChapter 2: Trends in recent deal activityM&A deal trends Key acquisitions in 2012 and the motives behind themMost acquisitive companies Licensing deal trends (Type of deal, Therapy area, Phase)Divesting - the other extremeFocus on: Deal activity in the generics sectorChapter 3: Successful deal makingKey steps to successful deal making www.aarkstore.com
Related Reports • Healthcare IT (HIT) Market in the APAC Region 2015-2019 • Complete 2015-16 Induced Pluripotent Stem Cell (iPSC) Industry Report • Latest Regulations on Pharmaceutical International Multi-Center Clinical Trials in China • Colposcopy Test, Market, Users & Forecast - Asia & Middle East Analysis • Point of Care Diagnostic Testing World Markets • Kidney Transplant Market, Numbers & Forecast for United States, Mexico & Canada • North American Laboratory Information System (LIS) Market www.aarkstore.com
Contact Us Office Office No. - 809, 8th Floor,B-Wing, Mahaavir Icon, Plot No.- 89 & 90, Sector-15,CBD-Belapur, Navi Mumbai – 400614, Maharashtra, India. 24/7 Online Support: +91 9987295242 General Inquiries : +91 - 22 2756 4953 You Can Visit http://www.aarkstore.com OR Mail us at contact@aarkstore.com Blog : http://www.aarkstore.com/blog/ Conference : http://conference.aarkstore.com/ News : http://www.aarkstore.com/news www.aarkstore.com